Diuretic Is PATHWAY to Resistant HTN Control

ACC Conference Reporter

ESC 2015 | LONDON — Adding the diuretic spironolactone brings resistant hypertension under control for most patients, with better results than other antihypertensives in that setting, the PATHWAY 2 trial showed. Read More >>>

Keywords: ESC Congress


< Back to Listings